Neil Harris Cohen, Director at Chemomab Therapeutics Ltd. (CMMB), bought 6,000 shares at $4.56 ($26K) on 2022-03-14, disclosed to the SEC on 2022-03-15.
Open-market purchase of $26k CMMB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.20 | 2,000 | $8K | 32.2% |
| 2 | $4.30 | 2,000 | $9K | 32.9% |
| 3 | $4.56 | 2,000 | $9K | 34.9% |
| Total | $4.35 avg | 6,000 | $26K | 100% |
| Filing → |
| CMMB | BUY | 2022-05-19 | $6K | — | Filing → |
| CMMB | BUY | 2021-12-08 | $15K | — | Filing → |
| CMMB | BUY | 2021-03-26 | $200K | — | Filing → |